Abstract:
Forty-five GM1-binding peptides were identified using phage-displayed peptides libraries of random peptides. Most have a motif containing a hydrophobic amino acid followed by a serine (S). Based on a GM1-binding assays, two of these GM1-binding peptides (named 15 and 40) were chosen to investigate its immunostimulatory properties when chemically coupled to antigens. Mice intra-nasally (i.n.) vaccinated with some of these complexes developed a better local and systemic antibody response than mice i.n. vaccinated with the respective uncoupled antigens. The efficiency of the complex GM 1-binding peptide-antigen strongly depends on the composition and structure of both of the components of the complex. © 2005 Elsevier Ltd. All rights reserved.
Registro:
Documento: |
Artículo
|
Título: | Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route |
Autor: | Montaner, A.D.; De Nichilo, A.; Elias, F.; Rodríguez, J.M.; Fló, J.M.; López, R.A.; Zorzopulos, J.; Frank, R. |
Filiación: | Instituto de Investigaciones Biomédicas, Fundación Pablo Cassará, Saladillo 2452, Buenos Aires C1440FFX, Argentina Immunotech S.A., Buenos Aires, Argentina Departamento de Química Biológica, FCEN, Universidad de Buenos Aires, Argentina Department of Chemical Biology, GBF (German Research Centre for Biotechnology), Braunschweig, Germany
|
Palabras clave: | GM1-binding peptides; Mucosal adjuvants; Phage display; bromacetyl beta alanyl beta alanylarginylseryllysylprolylprolyleucylserylprolylleucylglycyltyrosinamide; bromacetyl beta alanyl beta alanylprolylprolylserylprolylserylvalylserylhistidylarginylthreonyltyrosinamide; ganglioside GM1; immunological adjuvant; peptide; peptide library; serine; unclassified drug; amino acid composition; animal cell; animal experiment; antibody response; article; binding assay; controlled study; immunostimulation; inoculation; mouse; nonhuman; phage display; priority journal; protein motif; Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Bacterial; Antibodies, Viral; Antigens, Bacterial; Antigens, Viral; Bronchoalveolar Lavage Fluid; Cell Wall; Enzyme-Linked Immunosorbent Assay; G(M1) Ganglioside; Hemagglutinin Glycoproteins, Influenza Virus; Immunoglobulin A; Immunoglobulin G; Influenza Vaccines; Mice; Mice, Inbred BALB C; Neuraminidase; Peptide Library; Peptides; Protein Binding; Streptococcus pneumoniae |
Año: | 2006
|
Volumen: | 24
|
Número: | 11
|
Página de inicio: | 1889
|
Página de fin: | 1896
|
DOI: |
http://dx.doi.org/10.1016/j.vaccine.2005.10.037 |
Título revista: | Vaccine
|
Título revista abreviado: | Vaccine
|
ISSN: | 0264410X
|
CODEN: | VACCD
|
CAS: | ganglioside GM1, 37758-47-7; serine, 56-45-1, 6898-95-9; Adjuvants, Immunologic; Antibodies, Bacterial; Antibodies, Viral; Antigens, Bacterial; Antigens, Viral; G(M1) Ganglioside, 37758-47-7; Hemagglutinin Glycoproteins, Influenza Virus; Immunoglobulin A; Immunoglobulin G; Influenza Vaccines; Neuraminidase, EC 3.2.1.18; Peptide Library; Peptides
|
Registro: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0264410X_v24_n11_p1889_Montaner |
Referencias:
- Elson, C.O., Cholera toxin and its subunits as potential oral adjuvants (1989) Curr Top Microbiol Immunol, 146, pp. 29-33
- Lycke, N.H., Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens (1986) J Immunol, 59, pp. 301-308
- Van Ginkel, F.W., Jackson, R.J., Yuki, Y., McGhee, J.R., Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues (2000) J Immunol, 165, pp. 4778-4782
- Neutra, M.R., Phillips, T.L., Mayer, E.L., Fishkind, D.J., Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch (1987) Cell Tissue Res, 247, pp. 537-546
- Pizza, M., Giuliani, M.M., Fontana, M.R., Monaci, E., Douce, G., Dougan, G., Mucosal vaccines: Non toxic derivatives of LT and CT as mucosal adjuvants (2001) Vaccine, 19, pp. 2534-2541
- Van Ginkel, F.W., Noda, N., Takeda, Y., McGhee, J.R., A non-toxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity (1997) Proc Natl Acad Sci USA, 94, p. 5267
- Yamamoto, M., Kimono, H., Yamamoto, S., Batanero, E., Quejón, M.N., Otake, S., Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant (1999) Immunol, 162, p. 7015
- Zhang, T., Li, E., Stanley, S.L., Oral Immunization with the dodecapeptide repeat of the serine-rich entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response (1995) Infect Immun, 63, pp. 1349-1355
- Hathaway, L.J., Obeid, O.E., Steward, M.W., Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen (1998) Vaccine, 6 (2-3), pp. 135-141
- Candí, A.G., Ericsson, K., Lebens, M., Nordstrom, I., Schon, E., Holgren, J., Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression an antigen-presenting cells (2001) Infect Immun, 69 (9), pp. 5716-5725
- Shen, X., Lagergard, T., Yang, Y., Lindblad, M., Fredriksson, M., Holmgren, J., Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization (2000) Vaccine, 19 (7), pp. 850-861
- Shen, X., Lagergard, T., Yang, Y., Lindblad, M., Fredriksson, M., Holmgren, J., Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine (2000) Infect Immun, 68 (10), pp. 5749-5755
- Dertzbaugh, M.T., Elson, C.O., Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition (1993) Infect Immun, 61 (2), pp. 384-390
- Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R.T., Linder, T., Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland (2004) N Engl J Med, 350, pp. 896-903
- Sambrook, J., Fritsch, E.F., Maniatis, T., (1989) Molecular Cloning: A Laboratory Manual, , 2nd ed. Cold Spring Harbor Laboratory Harbor Cold Spring, NY
- Frank, R., (1992) Tetrahedr Lett, 48, p. 9217
- Frank, R., Overwin, H., (1996) Methods in Molecular Biology Epitope Mapping Protocols, 66. , The Humana Press Inc Totowa
- Matsubara, T., Ishikawa, D., Taki, T., Okahata, Y., Sato, T., Selection of ganglioside GM1-binding peptides by using a phage library (1999) FEBS Lett, 456, pp. 253-256
- Englebretsen, D.R., Gamham, B.D., Bergman, D.A., Alewood, P.F., A novel Tioether linker: Chemical synthesis of a HIV-1 protease analogue by thioether ligation (1995) Tetrahedr Lett, 36, pp. 8871-8874
- Hancock, I.C., (1994) Chemical Methods in Prokaryotic Systematics, , John Wiley & Sons USA
- Coligan, J.E., (2000) Current Protocols in Protein Science, 1. , John Wiley & Sons Inc USA
- Zhang, R.G., Scott, D.L., Westbrook, M.L., Nance, S., Spangler, B.D., Shipley, G.G., The three-dimensional crystal structure of cholera toxin (1995) J Mol Biol, 251, pp. 563-573
- Merritt, E.A., Sarfaty, S., Van Den Akker, F., L'Hoir, C., Martial, J.A., Hol, W.G.J., Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide (1994) Protein Sci, 3, pp. 166-175
- Jobling, M.G., Holmes, R.K., Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras (2002) Infect Immun, 70 (3), pp. 1260-1271
- Neutra, M.R., Kraehenbuhl, J.P., M cells as a pathway for antigen uptake and processing (1996) Mucosal Immunology, , Academic Press USA
- Holmgren, J., Adamsson, J., Anjuere, F., Clemens, J., Czerkinsky, C., Eriksson, K., Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA (2005) Immunol Lett, 97 (2), pp. 181-188
Citas:
---------- APA ----------
Montaner, A.D., De Nichilo, A., Elias, F., Rodríguez, J.M., Fló, J.M., López, R.A., Zorzopulos, J.,..., Frank, R.
(2006)
. Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route. Vaccine, 24(11), 1889-1896.
http://dx.doi.org/10.1016/j.vaccine.2005.10.037---------- CHICAGO ----------
Montaner, A.D., De Nichilo, A., Elias, F., Rodríguez, J.M., Fló, J.M., López, R.A., et al.
"Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route"
. Vaccine 24, no. 11
(2006) : 1889-1896.
http://dx.doi.org/10.1016/j.vaccine.2005.10.037---------- MLA ----------
Montaner, A.D., De Nichilo, A., Elias, F., Rodríguez, J.M., Fló, J.M., López, R.A., et al.
"Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route"
. Vaccine, vol. 24, no. 11, 2006, pp. 1889-1896.
http://dx.doi.org/10.1016/j.vaccine.2005.10.037---------- VANCOUVER ----------
Montaner, A.D., De Nichilo, A., Elias, F., Rodríguez, J.M., Fló, J.M., López, R.A., et al. Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal route. Vaccine. 2006;24(11):1889-1896.
http://dx.doi.org/10.1016/j.vaccine.2005.10.037